JP Morgan Chase’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.83M Buy
67,500
+34,500
+105% +$1.48M ﹤0.01% 3831
2025
Q4
$1.45M Buy
33,000
+18,600
+129% +$769K ﹤0.01% 4348
2025
Q3
$595K Buy
14,400
+4,400
+44% +$177K ﹤0.01% 4921
2025
Q2
$441K Sell
10,000
-17,600
-64% -$703K ﹤0.01% 4848
2025
Q1
$1.02M Buy
+27,600
New +$983K ﹤0.01% 4335
2024
Q2
Sell
-70,000
Closed -$1.66M 7461
2024
Q1
$1.66M Buy
+70,000
New +$1.56M ﹤0.01% 3990
2023
Q1
Sell
-2,000
Closed -$32K 6848
2022
Q4
$32K Buy
+2,000
New +$32.6K ﹤0.01% 5742
2018
Q1
Sell
-290,000
Closed -$8.82M 5457
2017
Q4
$8.82M Hold
290,000
﹤0.01% 2221
2017
Q3
$7.03M Hold
290,000
﹤0.01% 2288
2017
Q2
$7.14M Sell
290,000
-69,000
-19% -$1.46M ﹤0.01% 2219
2017
Q1
$7.78M Buy
359,000
+159,000
+80% +$3.23M ﹤0.01% 2107
2016
Q4
$2.98M Buy
+200,000
New +$2.89M ﹤0.01% 2828

Other funds holding EXEL

JP Morgan Chase's EXEL Position: Q1 2026 in Review

JP Morgan Chase increased its Exelixis (EXEL) stake by 6.9% in Q1 2026, buying an estimated $2.24M and bringing the position to 810,849 shares worth $34M. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

JP Morgan Chase first reported a position in EXEL in Q2 2013 and has held it in 45 quarters since. The position peaked at $273M in Q1 2022. 695 funds tracked by Wall St. Rank hold EXEL as of Q1 2026.

  • JP Morgan Chase held 810,849 shares of Exelixis worth $34M as of Q1 2026.
  • JP Morgan Chase bought 52,089 Exelixis shares in Q1 2026, an estimated $2.24M.
  • Exelixis made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1645 holding.
  • JP Morgan Chase first reported a position in Exelixis in Q2 2013 and has held it in 45 quarters since.
  • JP Morgan Chase's Exelixis position peaked at $273M in Q1 2022.
  • 695 funds tracked by Wall St. Rank held Exelixis as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.